Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Leukemia Chronic Lymphocytic Leukemia (CLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)UnknownNCT00022880
What this trial is testing

Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
Corixa Corporation 30
Testing effectiveness (Phase 2)Study completedNCT04010968
What this trial is testing

Evaluation of Risk-Adapted and MRD-Driven Strategy for Untreated Fit Patients With Intermediate Risk Chronic Lymphocytic Leukemia

Who this might be right for
Intermediate Risk Chronic Lymphocytic LeukemiaFit PatientsRisk-Adapted and MRD-Driven Strategy
French Innovative Leukemia Organisation 120
Testing effectiveness (Phase 2)Ended earlyNCT00183950
What this trial is testing

Study of Noscapine for Patients With Low Grade Non Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia Refractory to Chemotherapy

Who this might be right for
Non-Hodgkin's LymphomaChronic Lymphocytic Leukemia
University of Southern California 12
Testing effectiveness (Phase 2)Study completedNCT01010217
What this trial is testing

Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

Who this might be right for
Blood Stem Cell Transplant FailureLeukemiaHematologic Malignancies
M.D. Anderson Cancer Center 176
Early research (Phase 1)Study completedNCT00714103
What this trial is testing

8-Chloro-Adenosine in Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 11
Early research (Phase 1)Ended earlyNCT05244070
What this trial is testing

Evaluate the Safety and Tolerability of BMS-986403 in Participants With Relapsed and/or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-CellLymphoma
Bristol-Myers Squibb 5
Early research (Phase 1)Ended earlyNCT01076556
What this trial is testing

Cyclophosphamide, Alvocidib, and Rituximab in Treating Patients With High Risk B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaProlymphocytic LeukemiaRecurrent Small Lymphocytic Lymphoma+9 more
National Cancer Institute (NCI) 9
Testing effectiveness (Phase 2)Study completedNCT00003829
What this trial is testing

Chemotherapy in Treating Patients With Previously Untreated Chronic Lymphocytic Leukemia

Who this might be right for
Leukemia
Alliance for Clinical Trials in Oncology 34
Early research (Phase 1)Study completedNCT00036946
What this trial is testing

VEGF Trap in Treating Patients With Relapsed or Refractory Solid Tumors or Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
Regeneron Pharmaceuticals
Not applicableNot Yet RecruitingNCT06902025
What this trial is testing

JY231(JY231) Injection for the Treatment of Relapsed or Refractory B-Cell Leukemia

Who this might be right for
B-ALL
He Huang 24
Large-scale testing (Phase 3)Ended earlyNCT00416910
What this trial is testing

Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
German CLL Study Group 83
Early research (Phase 1)Study completedNCT02529813
What this trial is testing

CD19-Specific T-cells in Treating Patients With Advanced Lymphoid Malignancies

Who this might be right for
Acute Biphenotypic LeukemiaAcute Lymphoblastic LeukemiaBlasts 5 Percent or More of Bone Marrow Nucleated Cells+6 more
M.D. Anderson Cancer Center 26
Testing effectiveness (Phase 2)Study completedNCT00230282
What this trial is testing

Phase 2 Fludarabine, Cytoxan and FCCAM <Alemtuzumab> in Untreated B-Cell Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaB-cell LeukemiaChronic Leukemia+1 more
Steven E. Coutre 25
Large-scale testing (Phase 3)UnknownNCT00445497
What this trial is testing

Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutropenia

Who this might be right for
Brain and Central Nervous System TumorsLymphomaNeutropenia+3 more
Clatterbridge Centre for Oncology 400
Early research (Phase 1)Active Not RecruitingNCT00881920
What this trial is testing

Kappa-CD28 T Lymphocytes, Chronic Lymphocytic Leukemia, B-cell Lymphoma or Multiple Myeloma, CHARKALL

Who this might be right for
LymphomaMyelomaLeukemia
Baylor College of Medicine 54
Not applicableUnknownNCT02267590
What this trial is testing

Tissue Collection for Biomarkers Determining Resistance to Ibrutinib

Who this might be right for
Mantle Cell LymphomaChronic Lymphocytic Leukaemia
Royal Marsden NHS Foundation Trust 120
Testing effectiveness (Phase 2)Study completedNCT01024010
What this trial is testing

Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaStage 0 Chronic Lymphocytic LeukemiaStage I Chronic Lymphocytic Leukemia+7 more
Mayo Clinic 82
Early research (Phase 1)Study completedNCT00390117
What this trial is testing

AT7519M in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
LymphomaUnspecified Adult Solid Tumor, Protocol Specific
NCIC Clinical Trials Group 34
Not applicableStudy completedNCT04964908
What this trial is testing

Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia

Who this might be right for
Chronic Lymphocytic Leukemia
AstraZeneca 1,088
Testing effectiveness (Phase 2)WithdrawnNCT06247540
What this trial is testing

Venetoclax, Rituximab and Nivolumab in Combination for the Treatment of Richter's Transformation Arising From Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Recurrent Transformed Chronic Lymphocytic LeukemiaRefractory Transformed Chronic Lymphocytic LeukemiaRichter Syndrome+2 more
Northwestern University
Next Page